Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

We have retained our Neutral recommendation on Molina Healthcare Inc. (MOH - Analyst Report) despite impressive second quarter results due to rising medical costs, declining investment income and the negative impact of the healthcare reforms. This multi-state managed care organization carries a Zacks Rank #3 (Hold).

Why the Reiteration?

Molina’s operating earnings for the second quarter of 2013 came in at $0.34 per share, surpassing the Zacks Consensus Estimate by 9.7%. Results also rebounded from the year-ago quarter’s loss of $0.71 per share.

Molina’s robust growth in premium and service revenues, investment income and rental income are the highlights of the strong second-quarter. Premiums have been increasing over the past few years and contributing to the increased revenues.

The first half of 2013 witnessed the same trend driven by membership growth in Wisconsin and Washington as well as higher rates in Texas and Washington in the second half of 2012. The second largest component of revenues viz. service revenues also surged in the first half keeping up with the drift over the past few years.

Membership of Molina is expected to be boosted by the Lovelace Community Health Plans contract for the New Mexico Medicaid Salud! Program as it will transfer Lovelace’s Medicaid members to the Centennial Care Program in New Mexico, of which Molina is a part.

Furthermore the acquisition initiatives of Molina aimed at expanding its geographic reach are impressive. Of particular importance are the acquisition of Health Information Management and Abri Health. The pending acquisition of certain assets of Community Health Solutions is also expected to bolster its growing membership. In addition, despite the cash outlays for inorganic growth, Molina holds a healthy balance sheet.

On the tepid side rising medical care costs and hence overall operating expenses has been posing a risk to the operating leverage of the company and weighing on margins. Also, upcoming changes like a ban on annual and lifetime coverage caps, annual fees on health insurance companies and excise tax on high premium insurance policies, will likely increase expenses further.

Moreover, the low interest rate environment has been dragging down investment income of the company and thus Molina needs to hedge its investment portfolio from market fluctuations to prevent further decline.

Other Stocks to Consider

Other healthcare companies that are worth considering are Aetna Inc. (AET - Analyst Report), UnitedHealth Group Inc. (UNH - Analyst Report) and WellPoint Inc. (WLP - Analyst Report). All these stocks carry a favorable Zacks Rank #2 (Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
BITAUTO HOLD BITA 35.33 +14.82%
ANI PHARMACE ANIP 24.79 +14.66%
E HOUSECHINA EJ 10.99 +9.24%
CANADIAN SOL CSIQ 26.97 +7.15%
INTERNATIONA ICAGY 33.30 +5.38%